Sarepta Therapeutics (SRPT) Treasury Shares (2025 - 2026)

Sarepta Therapeutics' Treasury Shares history runs 16 years deep, the most recent figure standing at $655642.0 for Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $655642.0; the TTM figure through Mar 2026 stood at $655642.0 (changed N/A YoY), while the FY2025 annual figure was $650876.0, up 15.46% from the prior year.
• Treasury Shares for Q1 2026 stood at $25.3 million, roughly flat from $25.3 million in the prior quarter.
• The five-year high for Treasury Shares was $2.2 million in Q4 2023, with the low at -$651000.0 in Q2 2025.
• The 4-year median for Treasury Shares is $653259.0 (2025), against an average of $896088.3.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares surged 38.59% in 2022, then climbed 22.46% in 2023.
• Sarepta Therapeutics' Treasury Shares stood at $25.3 million in 2025, then changed by 0.0% to $25.3 million in 2026.
• Business Quant data shows SRPT's Treasury Shares at $25.3 million in Q1 2026, $25.3 million in Q4 2025, and $25.3 million in Q3 2025.